Main public logs

Combined display of all available logs of CAMIH. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).

• 12:07, 6 July 2024 EProba talk contribs created page Dale et al. (2001): Co-medication with hydrolytic enzymes in radiation therapy of uterine cervix: evidence of the reduction of acute side effects (Created page with "{{Reference |Reference=Publication: Co-medication with hydrolytic enzymes in radiation therapy of uterine cervix: evidence of the reduction of acute side effects }} {{Study Note |Study Note=? }} =Brief summary= 120 women with cervical cancer were included in this study. All patients received the same radiotherapy. One group of 60 people also received enzyme therapy in tablet form (10mg papain, 40mg trypsin, 40mg chymotrypsin), which was taken during the radiotherapy. Ano...")
• 11:26, 6 July 2024 EProba talk contribs created page Dale, P. S.; Tamhankar, C. P.; George, D.; Daftary, G. V. (Created page with "{{Author}}")
• 11:25, 6 July 2024 EProba talk contribs created page Publication: Co-medication with hydrolytic enzymes in radiation therapy of uterine cervix: evidence of the reduction of acute side effects (Created page with "{{Publication |Title=Co-medication with hydrolytic enzymes in radiation therapy of uterine cervix: evidence of the reduction of acute side effects |Topic=Enzymes (bromelain papain) |Author=Dale, P. S.; Tamhankar, C. P.; George, D.; Daftary, G. V. |Year=2001 |Journal=Cancer Chemotherapy and Pharmacology |DOI=https://doi.org/10.1007/s002800170006 |Authors Abstract=Purpose: The use of additional therapy with an oral enzyme preparation containing trypsin, chymotrypsin and pa...")
• 13:50, 5 July 2024 JDoerfler talk contribs created page Ghoreishi et al. (2007): Effect of vitamin E on chemotherapy-induced mucositis and neutropenia in leukemic patients undergoing bone marrow transplantation (Created page with "{{Reference |Reference=Publication: Effect of vitamin E on chemotherapy-induced mucositis and neutropenia in leukemic patients undergoing bone marrow transplantation }} {{Study Note}} =Brief summary= In this study, various leukemia patients were divided into two different arms prior to bone marrow transplantation. One arm began taking vitamin E seven days before the operation until 28 days afterwards in addition to chemotherapy, while the other received only a placebo in...")
• 13:48, 5 July 2024 JDoerfler talk contribs created page Publication: Effect of vitamin E on chemotherapy-induced mucositis and neutropenia in leukemic patients undergoing bone marrow transplantation (Created page with "{{Publication |Title=Effect of vitamin E on chemotherapy-induced mucositis and neutropenia in leukemic patients undergoing bone marrow transplantation |Topic=Vitamin E |Author=Ghoreishi, Z; Shidfar, F; Iravani, M; Esfahani, A; Ghavamzadeh, A |Year=2007 |Journal=Asia-Pacific Journal of Clinical Oncology |DOI=https://10.1111/j.1743-7563.2007.00111.x |Authors Abstract=Aim: This study was conducted to investigate the effect of oral vitamin E on mucositis and neutropenia in p...")
• 12:34, 5 July 2024 JDoerfler talk contribs created page Ferreira et al. (2004): Protective effect of alpha-tocopherol in head and neck cancer radiation-induced mucositis: A double-blind randomized trial (Created page with "{{Reference |Reference=Publication: Protective effect of alpha-tocopherol in head and neck cancer radiation-induced mucositis: A double-blind randomized trial }} {{Study Note}} =Brief summary= In this study, patients with head and neck tumors were divided into two different arms before radiotherapy. One arm received additional vitamin E throughout the radiotherapy and the other arm only a placebo. There were significantly fewer cases of oral mucositis (i.e. inflammation...")
• 12:10, 5 July 2024 JDoerfler talk contribs created page Publication: Protective effect of alpha-tocopherol in head and neck cancer radiation-induced mucositis: A double-blind randomized trial (Created page with "{{Publication |Title=Protective effect of alpha-tocopherol in head and neck cancer radiation-induced mucositis: A double-blind randomized trial |Topic=Vitamin E |Author=Ferreira, PR; Fleck, JF; Diehl, A; Barletta, D; Braga-Filho, A; Barletta, A; Ilha, L |Year=2004 |Journal=Head and Neck |DOI=https://10.1002/hed.10382 |Authors Abstract=Abstract: Background. The study was designed to test whether vitamin E (VE) provides oral mucosal protection in patients with irradiated c...")
• 11:29, 5 July 2024 JDoerfler talk contribs created page Fallahi et al. (2013): Does vitamin E protect salivary glands from I-131 radiation damage in patients with thyroid cancer? (Created page with "{{Reference |Reference=Publication: Does vitamin E protect salivary glands from I-131 radiation damage in patients with thyroid cancer? }} {{Study Note |Study Note=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=? |Specifications on an...")
• 11:21, 5 July 2024 JDoerfler talk contribs created page Publication: Does vitamin E protect salivary glands from I-131 radiation damage in patients with thyroid cancer? (Created page with "{{Publication |Title=Does vitamin E protect salivary glands from I-131 radiation damage in patients with thyroid cancer? |Topic=Vitamin E |Author=Fallahi, B; Beiki, D; Abedi, SM; Saghari, M; Fard-Esfahani, A; Akhzari, F; Mokarami, B; Eftekhari, M |Year=2013 |Journal=Nuclear medicine communications |DOI=https://10.1097/MNM.0b013e328362b1f2 |Authors Abstract=Objectives Salivary gland impairment after high-dose radioiodine (131I) treatment is well recognized. The aim of thi...")
• 10:17, 5 July 2024 CHoppe talk contribs created page Walsh et al. (2010): Use of alpha,25-dihydroxyvitamin D3 treatment to stimulate immune infiltration into head and neck squamous cell carcinoma (Created page with "{{Reference |Reference=Publication: Use of alpha,25-dihydroxyvitamin D3 treatment to stimulate immune infiltration into head and neck squamous cell carcinoma }} {{Study Note |Study Note=In this study, two groups of neck and head tumor patients were compared with regard to the progression-free interval. One group received vitamin D for 3 weeks before the tumor operation and the other group received nothing. In the vitamin D group, it took significantly longer for the dise...")
• 10:16, 5 July 2024 CHoppe talk contribs created page Publication: Use of alpha,25-dihydroxyvitamin D3 treatment to stimulate immune infiltration into head and neck squamous cell carcinoma (Created page with "{{Publication |Title=Use of alpha,25-dihydroxyvitamin D3 treatment to stimulate immune infiltration into head and neck squamous cell carcinoma |Topic=Vitamin D |Author=Walsh, JE; Clark A-M; Day, TA; Gillespie, MB; Young, MRI |Year=2010 |Journal=Human immunology |DOI=10.1016/j.humimm.2010.04.008 |Authors Abstract=Prior studies have shown that treatment of head and neck squamous cell carcinoma (HNSCC) patients with 1alpha,25-dihydroxyvitamin D(3) [1,25(OH)(2)D(3)] reduced...")
• 09:22, 5 July 2024 JDoerfler talk contribs created page Delanian et al. (2003): Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis (Created page with "{{Reference |Reference=Publication: Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis }} {{Study Note |Study Note=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-9...")
• 09:21, 5 July 2024 JDoerfler talk contribs created page Publication: Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis (Created page with "{{Publication |Title=Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis |Topic=Vitamin E |Author=Delanian, S; Porcher, R; Balla-Mekias, S; Lefaix, J-L |Year=2003 |Journal=Journal of clinical Oncology |DOI=https://10.1200/JCO.2003.06.064 |Authors Abstract=Purpose: Radiation-induced fibrosis (RIF) is a rare morbid complication of radiotherapy, without an established method of management. R...")
• 14:27, 4 July 2024 JDoerfler talk contribs created page Barton et al. (1998): Prospective evaluation of vitamin E for hot flashes in breast cancer survivors (Created page with "{{Reference |Reference=Publication: Prospective evaluation of vitamin E for hot flashes in breast cancer survivors }} {{Study Note |Study Note=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=? |Specifications on analyses=? |Countries o...")
• 14:26, 4 July 2024 JDoerfler talk contribs created page Publication: Prospective evaluation of vitamin E for hot flashes in breast cancer survivors (Created page with "{{Publication |Title=Prospective evaluation of vitamin E for hot flashes in breast cancer survivors |Topic=Vitamin E |Author=Barton, DL; Loprinzi, CL; Quella, SK; Sloan, JA; Veeder, MH; Egner, JR; Fidler, P; Stella, PJ; Swan, DK; Vaught, NL; Novotny, P |Year=1998 |Journal=Journal of clinical Oncology |DOI=https://doi.org/10.1200/JCO.1998.16.2.495 |Authors Abstract=Purpose Hot flashes are a significant issue for many breast cancer survivors, with concerns over the use of...")
• 14:18, 4 July 2024 JDoerfler talk contribs created page Bairati et al. (2005): A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients (Created page with "{{Reference |Reference=Publication: A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients }} {{Study Note |Study Note=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=? |Specificat...")
• 14:17, 4 July 2024 JDoerfler talk contribs created page Publication: A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients (Created page with "{{Publication |Title=A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients |Topic=Vitamin E |Author=Bairati, I; Meyer, F; Gélinas, M; Fortin, A; Nabid, A; Brochet, F; Mercier, J. P; Têtu, B; Harel, F; Mâsse, B; Vigneault, É; Vass, S; del Vecchio, P; Roy, J |Year=2005 |Journal=Journal of the National Cancer Institute |DOI=https://10.1093/jnci/dji095 |Authors Abstract=Background: Although low dietary intakes of an...")
• 14:00, 4 July 2024 CHoppe talk contribs created page Shapiro et al. (2016): Randomized, blinded trial of vitamin D3 for treating aromatase inhibitor-associated musculoskeletal symptoms (AIMSS) (Created page with "{{Reference |Reference=Publication: Randomized, blinded trial of vitamin D3 for treating aromatase inhibitor-associated musculoskeletal symptoms (AIMSS) }} {{Study Note}} =Brief summary= This study investigated the efficacy of high-dose vitamin D3 with regard to muscular symptoms associated with aromatase inhibitors. No significant differences were found between the arms that received high-dose vitamin D and the control arm that only received standard vitamin D therapy....")
• 13:56, 4 July 2024 CHoppe talk contribs created page Publication: Randomized, blinded trial of vitamin D3 for treating aromatase inhibitor-associated musculoskeletal symptoms (AIMSS) (Created page with "{{Publication |Title=Randomized, blinded trial of vitamin D3 for treating aromatase inhibitor-associated musculoskeletal symptoms (AIMSS) |Topic=Vitamin D |Author=Shapiro, AC; Adlis, SA; Robien, K; Kirstein, MN; Liang, S; Richter, SA; Lerner, RE |Year=2016 |Journal=Breast cancer Research and Treatment |DOI=10.1007/s10549-016-3710-6 |Authors Abstract=Purpose: To evaluate the efficacy and safety of vitamin D3 at 4,000 IU/day as a treatment option for aromatase inhibitor as...")
• 13:37, 4 July 2024 JDoerfler talk contribs created page Azizi et al. (2015): Efficacy of Topical and Systemic Vitamin E in Preventing Chemotherapy-induced Oral Mucositis (Created page with "{{Reference |Reference=Publication: Efficacy of Topical and Systemic Vitamin E in Preventing Chemotherapy-induced Oral Mucositis }} {{Study Note |Study Note=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=? |Specifications on analyses=...")
• 13:37, 4 July 2024 JDoerfler talk contribs created page Publication: Efficacy of Topical and Systemic Vitamin E in Preventing Chemotherapy-induced Oral Mucositis (Created page with "{{Publication |Title=Efficacy of Topical and Systemic Vitamin E in Preventing Chemotherapy-induced Oral Mucositis |Topic=Vitamin E |Author=Azizi, A; Alirezaei, S; Pedram, P; Mafi, AR |Year=2015 |Journal=Reports of Radiotherapy and Oncology |DOI=https://0.5812/rro.2(1)2015.796 |Authors Abstract=Background: There is still no consensus regarding the optimum treatment of chemotherapy-induced oral mucositis, and its management is still mainly supportive. Vitamin E has been sh...")
• 13:09, 4 July 2024 JDoerfler talk contribs created page Argyriou et al. (2006): Preventing Paclitaxel-Induced Peripheral neuropathy: A Phase 2 Trial of Vitamin E Supplementation (Created page with "{{Reference |Reference=Publication: A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for protection against cisplatin-induced peripheral neuropathy: final results }} {{Study Note |Study Note=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |E...")
• 13:08, 4 July 2024 JDoerfler talk contribs created page Publication: Preventing Paclitaxel-Induced Peripheral neuropathy: A Phase 2 Trial of Vitamin E Supplementation (Created page with "{{Publication |Title=Preventing Paclitaxel-Induced Peripheral neuropathy: A Phase 2 Trial of Vitamin E Supplementation |Topic=Vitamin E |Author=Argyriou, AA; Chroni, E; Koutras, A; Iconomou, G; Papapetropoulos, S; Polychronopoulos, P; Kalofonos, HP |Year=2006 |Journal=Journal of Pain and Symptom Management |DOI=https://10.1016/j.jpainsymman.2006.03.013 |Authors Abstract=A randomized, controlled trial was performed to assess the efficacy and safety of vitamin E supplement...")
• 11:54, 4 July 2024 CHoppe talk contribs created page Scher et al. (2011): Randomized, open-label phase III trial of docetaxel plus high-dose calcitriol versus docetaxel plus prednisone for patients with castration-resistant prostate cancer (Created page with "{{Reference |Reference=Publication: Randomized, open-label phase III trial of docetaxel plus high-dose calcitriol versus docetaxel plus prednisone for patients with castration-resistant prostate cancer }} {{Study Note}} =Brief summary= In this study, prostate cancer patients were examined, with one half receiving docetaxel and a vitamin D analog (arm A) and the other half docetaxel and prednisone (arm B). Patients in arm A lived significantly shorter than those in arm B....")
• 11:52, 4 July 2024 CHoppe talk contribs created page Publication: Randomized, open-label phase III trial of docetaxel plus high-dose calcitriol versus docetaxel plus prednisone for patients with castration-resistant prostate cancer (Created page with "{{Publication |Title=Randomized, open-label phase III trial of docetaxel plus high-dose calcitriol versus docetaxel plus prednisone for patients with castration-resistant prostate cancer |Topic=Vitamin D |Author=Scher, H; Jia, X; Chi, K; Wit, R de; Berry, WR; Albers, P; Henick, B; Waterhouse, D; Ruether, DJ; Rosen, PJ; Meluch, AA; Nordquist, LT; Venner, PM; Heidenreich, A; Chu, L; Heller, G |Year=2011 |Journal=Journal of Clinical Oncology |DOI=10.1200/JCO.2010.32.8815 |A...")
• 11:33, 4 July 2024 DDeel talk contribs created page Publication: A Randomized Trial of Antioxidant Vitamins to Prevent Second Primary Cancers in Head and Neck Cancer Patients (Created page with "{{Publication |Title=A Randomized Trial of Antioxidant Vitamins to Prevent Second Primary Cancers in Head and Neck Cancer Patients |Topic=Vitamin A (beta-carotene), Vitamin E |Author=Bairati, I; Meyer, F; Gélinas, M; Fortin, A; Nabid, A; Brochet, F; Mercier, J; Têtu, B; Harel, F; Mâsse, B; Vigneault, É; Vass, S; del Vecchio, P; Roy, J |Year=2005 |Journal=Journal of the National Cancer Institute |DOI=https://doi.org/10.1093/jnci/dji095 |Authors Abstract=Background: Al...")
• 11:30, 4 July 2024 JDoerfler talk contribs created page Argyriou et al. (2006): A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for protection against cisplatin-induced peripheral neuropathy: final results (Created page with "{{Reference |Reference=? }} {{Study Note |Study Note=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=? |Specifications on analyses=? |Countries of data collection=? |LoE=? |Outcome timeline=? }} =Characteristics of participants= {{Cha...")
• 11:29, 4 July 2024 JDoerfler talk contribs deleted page Publication: A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for pretection against cisplatin-induced peripheral neuropathy: final results (content was: "{{Publication |Title=A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for pretection against cisplatin-induced peripheral neuropathy: final results |Topic=Vitamin E |Author=Argyriou, AA; Chroni, E; Koutras, A; Iconomou, G; Papapetropoulos, S; Polychronopoulos, P; Kalofonos, HP |Year=2006 |Journal=Supportive care in cancer |DOI...", and the only contributor was "JDoerfler" (talk))
• 11:29, 4 July 2024 JDoerfler talk contribs created page Publication: A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for protection against cisplatin-induced peripheral neuropathy: final results (Created page with "{{Publication |Title=A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for pretection against cisplatin-induced peripheral neuropathy: final results |Topic=Vitamin E |Author=Argyriou, AA; Chroni, E; Koutras, A; Iconomou, G; Papapetropoulos, S; Polychronopoulos, P; Kalofonos, HP |Year=2006 |Journal=Supportive care in cancer |DOI=https://10.1007/s00520-006-0072-3 |Authors Abstract=Aim: A randomized, open-label with blind assessme...")
• 11:26, 4 July 2024 JDoerfler talk contribs created page Publication: A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for pretection against cisplatin-induced peripheral neuropathy: final results (Created page with "{{Publication |Title=A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for pretection against cisplatin-induced peripheral neuropathy: final results |Topic=Vitamin E |Author=Argyriou, AA; Chroni, E; Koutras, A; Iconomou, G; Papapetropoulos, S; Polychronopoulos, P; Kalofonos, HP |Year=2006 |Journal=Supportive care in cancer |DOI=https://10.1007/s00520-006-0072-3 |Authors Abstract=Aim: A randomized, open-label with blind assessme...")
• 10:34, 4 July 2024 CHoppe talk contribs created page Rastelli et al. (2011): Vitamin D and aromatase inhibitor-induced musculoskeletal symptoms (AIMSS): a phase II, double-blind, placebo-controlled, randomized trial (Created page with "{{Reference |Reference=Publication: Vitamin D and aromatase inhibitor-induced musculoskeletal symptoms (AIMSS): a phase II, double-blind, placebo-controlled, randomized trial }} {{Study Note}} =Brief summary= In this study, breast cancer patients who had already received aromatase inhibitor therapy for at least 8 weeks before the start of the study were examined with regard to typical side effects (musculoskeletal disorders, AIMSS) of this treatment. One arm received vit...")
• 10:30, 4 July 2024 CHoppe talk contribs created page Publication: Vitamin D and aromatase inhibitor-induced musculoskeletal symptoms (AIMSS): a phase II, double-blind, placebo-controlled, randomized trial (Created page with "{{Publication |Title=Vitamin D and aromatase inhibitor-induced musculoskeletal symptoms (AIMSS): a phase II, double-blind, placebo-controlled, randomized trial |Topic=Vitamin D |Author=Rastelli, AL; Taylor, ME; Gao, F; Armamento-Villareal, R; Jamalabadi-Majidi, S; Napoli, N; Ellis, MJ |Year=2011 |Journal=Breast Cancer Research and Treatment. |DOI=10.1007/s10549-011-1644-6 |Authors Abstract=Abstract A double-blind placebo-controlled randomized phase II trial was performed...")
• 09:33, 4 July 2024 Cotto talk contribs changed group membership for Lbordihn from (none) to interface administrator, bureaucrat, suppressor, curator (Semantic MediaWiki) and editor (Semantic MediaWiki)
• 08:57, 4 July 2024 EProba talk contribs created page Stendell-Hollis et al. (2010): Green tea improves metabolic biomarkers, not weight or body composition: a pilot study in overweight breast cancer survivors (Created page with "{{Reference |Reference=Publication: Green tea improves metabolic biomarkers, not weight or body composition: a pilot study in overweight breast cancer survivors }} {{Study Note |Study Note=? }} =Brief summary= In this study, 54 overweight patients who had survived breast cancer were divided into one of two groups. One group drank 960ml of caffeine-free green tea (including 128.84mg EGCG) daily for 6 months and the control group drank herbal tea. Neither the participants...")
• 08:15, 4 July 2024 EProba talk contribs created page Stendell-Hollis, N. R.; Thomson, C. A.; Thompson, P. A.; Bea, J. W.; Cussler, E. C.; Hakim, I. A. (Created page with "{{Author}}")
• 08:15, 4 July 2024 EProba talk contribs created page Publication: Green tea improves metabolic biomarkers, not weight or body composition: a pilot study in overweight breast cancer survivors (Created page with "{{Publication |Title=Green tea improves metabolic biomarkers, not weight or body composition: a pilot study in overweight breast cancer survivors |Topic=Green tea (EGCG) |Author=Stendell-Hollis, N. R.; Thomson, C. A.; Thompson, P. A.; Bea, J. W.; Cussler, E. C.; Hakim, I. A. |Year=2010 |Journal=Journal of human nutrition and dietetics: the official journal of the British Dietetic Association |DOI=https://doi.org/10.1111/j.1365-277X.2010.01078.x |Authors Abstract=Backgrou...")
• 07:33, 4 July 2024 CHoppe talk contribs created page Nasser et al. (2017): Vitamin D ointment for prevention of radiation dermatitis in breast cancer patients (Created page with "{{Reference |Reference=Publication: Vitamin D ointment for prevention of radiation dermatitis in breast cancer patients }} {{Study Note}} =Brief summary= In this study, the effectiveness of a vitamin D ointment was investigated with regard to typical adverse skin reactions associated with radiotherapy treatment. Breast cancer patients were given a vitamin D ointment on one side of the treated breast and a normal control ointment on the other half. There were no significa...")
• 07:31, 4 July 2024 CHoppe talk contribs created page Publication: Vitamin D ointment for prevention of radiation dermatitis in breast cancer patients (Created page with "{{Publication |Title=Vitamin D ointment for prevention of radiation dermatitis in breast cancer patients |Topic=Vitamin D |Author=Nasser, NJ; Fenig, S; Ravid, A; Nouriel, A; Ozery, N; Gardyn, S; Koren, R; Fenig, E |Year=2017 |Journal=NPJ Breast Cancer |DOI=10.1038/s41523-017-0006-x |Authors Abstract=Radiation dermatitis occurs frequently during adjuvant radiation therapy for breast cancer. Prevention of radiation dermatitis by applying various creams and ointments has a...")
• 12:02, 3 July 2024 Cotto talk contribs created page TestPublication (Created page with "{{Publication |Title=Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology |Topic=Selenium |Author=Muecke, R; Schomburg, L; Glatzel, M; Berndt-Skorka, R; Baaske, D; Reichl, B; Buentzel, J; Kundt, G; Prott, FJ; Devries, A; Stoll, G; Kisters, K; Bruns, F; Schaefer, U; Willich, N; Micke, O |Year=2010 |Journal=International Journal of Radiation Oncology – Biology – Physics |DOI=https://doi.org/10.1016/j.ijrobp.20...")
• 11:59, 3 July 2024 Cotto talk contribs created page Publication: Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology (Created page with "{{Publication |Title=Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology |Topic=Selenium |Author=Muecke, R; Schomburg, L; Glatzel, M; Berndt-Skorka, R; Baaske, D; Reichl, B; Buentzel, J; Kundt, G; Prott, FJ; Devries, A; Stoll, G; Kisters, K; Bruns, F; Schaefer, U; Willich, N; Micke, O |Year=2010 |Journal=International Journal of Radiation Oncology – Biology – Physics |DOI=https://doi.org/10.1016/j.ijrobp.20...")
• 11:54, 3 July 2024 Cotto talk contribs deleted page Publication: Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology (content was: "{{Publication |Title=Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology |Topic=Selenium |Author=Muecke, R; Schomburg, L; Glatzel, M; Berndt-Skorka, R; Baaske, D; Reichl, B; Buentzel, J; Kundt, G; Prott, FJ; Devries, A; Stoll, G; Kisters, K; Bruns, F; Schaefer, U; Willich, N; Micke, O |Year=2010 |Journal=International Jour...", and the only contributor was "Cotto" (talk))
• 11:47, 3 July 2024 Cotto talk contribs created page Publication: Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology (Created page with "{{Publication |Title=Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology |Topic=Selenium |Author=Muecke, R; Schomburg, L; Glatzel, M; Berndt-Skorka, R; Baaske, D; Reichl, B; Buentzel, J; Kundt, G; Prott, FJ; Devries, A; Stoll, G; Kisters, K; Bruns, F; Schaefer, U; Willich, N; Micke, O |Year=2010 |Journal=International Journal of Radiation Oncology – Biology – Physics |DOI=https://doi.org/10.1016/j.ijrobp.20...")
• 11:46, 3 July 2024 Cotto talk contribs deleted page Publication: Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology (content was: "{{Publication |Title=Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology |Topic=Selenium |Author=Muecke, R; Schomburg, L; Glatzel, M; Berndt-Skorka, R; Baaske, D; Reichl, B; Buentzel, J; Kundt, G; Prott, FJ; Devries, A; Stoll, G; Kisters, K; Bruns, F; Schaefer, U; Willich, N; Micke, O |Year=2010 |Journal=International Journal of Radiation Oncology – Biology – Physics |DOI=https://doi.org/10.1016/j.ijrobp.2009.08.0...")
• 11:46, 3 July 2024 Cotto talk contribs created page Muecke et al. (2010): Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology (Created page with "{{Reference |Reference=Publication: Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology }} =Brief summary= This study included 81 patients with uterine or cervical cancer. They were randomly divided into two arms and received either 500µg selenium in addition to radiotherapy or no additional preparations. All participants had a selenium deficiency at the beginning of the study. After about 7 weeks and thus the...")
• 11:45, 3 July 2024 Cotto talk contribs deleted page Muecke et al. (2010): Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology (content was: "{{Reference |Reference=Publication: Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology }} =Brief summary= This study included 81 patients with uterine or cervical cancer. They were randomly divided into two arms and received either 500µg selenium in addition to radiotherapy or no additional preparations. All participants...", and the only contributor was "Cotto" (talk))
• 11:45, 3 July 2024 Cotto talk contribs created page Muecke et al. (2010): Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology (Created page with "{{Reference |Reference=Publication: Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology }} =Brief summary= This study included 81 patients with uterine or cervical cancer. They were randomly divided into two arms and received either 500µg selenium in addition to radiotherapy or no additional preparations. All participants had a selenium deficiency at the beginning of the study. After about 7 weeks and thus the...")
• 11:44, 3 July 2024 Cotto talk contribs deleted page Muecke et al. (2010): Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology (content was: "{{Reference |Reference=Publication: Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology }} =Brief summary= This study included 81 patients with uterine or cervical cancer. They were randomly divided into two arms and received either 500µg selenium in addition to radiotherapy or no additional preparations. All participants had a selenium deficiency at the beginning of the study. After about 7 weeks and thus the end of...")
• 11:29, 3 July 2024 Cotto talk contribs created page Template:Study Note (Created page with "<noinclude> {{#template_params:}} </noinclude><includeonly>{| class="wikitable" |- ! |{{#ask:[[ALlows value::{{SUBJECTPAGENAME}}]]|format=list}} |} </includeonly>")
• 11:24, 3 July 2024 Cotto talk contribs created page Property:Study Note (Created a property of type Text)
• 11:15, 3 July 2024 Cotto talk contribs created page Template:Additional Notes (Created page with "<noinclude> {{#template_params:}} </noinclude><includeonly>{| class="wikitable" |- ! |{{#ask:[[ALlows value::{{SUBJECTPAGENAME}}]]|format=list}} |} </includeonly>")